Inrebic Fedratinib — Carefirst Caremark
4 indications indexed for this drug.
- Accelerated Phase Or Blast Phase Myeloproliferative NeoplasmView coverage criteria
- Intermediate 2 Or High Risk Primary Or Secondary Post PolycyView coverage criteria
- Myeloid And Or Lymphoid Neoplasms With Eosinophilia And Jak2View coverage criteria
- Splenomegaly And Other Disease Related Symptoms Of Mf AssociView coverage criteria